[Resistance to anti-angiogenic therapy: a clinical and scientific current issue].

about

[Resistance to anti-angiogenic therapy: a clinical and scientific current issue].

Item

http://www.wikidata.org/entity/Q53787748

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

[Resistance to anti-angiogenic therapy: a clinical and scientific current issue].

@en

[Resistance to anti-angiogenic therapy: a clinical and scientific current issue].

@nl

type

Item

label

[Resistance to anti-angiogenic therapy: a clinical and scientific current issue].

@en

[Resistance to anti-angiogenic therapy: a clinical and scientific current issue].

@nl

prefLabel

[Resistance to anti-angiogenic therapy: a clinical and scientific current issue].

@en

[Resistance to anti-angiogenic therapy: a clinical and scientific current issue].

@nl

P1476

[Resistance to anti-angiogenic therapy: a clinical and scientific current issue].

@en

P2093

Anne Janin

http://www.w3.org/2001/XMLSchema#string

Guilhem Bousquet

http://www.w3.org/2001/XMLSchema#string

Hong Li

http://www.w3.org/2001/XMLSchema#string

Mélanie Di Benedetto

http://www.w3.org/2001/XMLSchema#string

Yuchen Gu

http://www.w3.org/2001/XMLSchema#string

P2860

Modes of resistance to anti-angiogenic therapy

Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Tumor endothelial cells

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Oncologic trogocytosis of an original stromal cells induces chemoresistance of ovarian tumours

Microenvironmental regulation of metastasis

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

Fibroblast growth factor-2 gene transfer can stimulate hepatocyte growth factor expression irrespective of hypoxia-mediated downregulation in ischemic limbs.

Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration.

Angiogenesis inhibitors: current strategies and future prospects.

P304

370-377

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1051/MEDSCI/20163204015

http://www.w3.org/2001/XMLSchema#string

P407

Af-Faransiis

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Catherine Boisson-Vidal

He Lu

P577

2016-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27137694

http://www.w3.org/2001/XMLSchema#string